Article

Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection

2023-08-25

Abstract excerpt

Coronavirus disease 2019 (COVID-19) vaccines have saved millions of lives. However, variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged causing large numbers of breakthrough infections. These developments necessitated the rollout of COVID-19 vaccine booster doses. It has been reported that mucosal antibody levels in the upper respiratory tract, especially for secretory IgA (sIgA),...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6958b3aa-f03d-5295-b40f-671e8113e370
DOI: 10.1101/2023.08.24.554732

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infectionDOI 10.1101/2023.08.24.554732Read

Milk Antibody Response after 3rd Dose of COVID-19 mRNA Vaccine and SARS-CoV-2 Breakthrough Infection and Implications for Infant ProtectionSemantic proximity Read

A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent PatientsSemantic proximity Read

A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent PatientsSemantic proximity Read

Mucosal Immune Response in BNT162b2 COVID-19 Vaccine RecipientsSemantic proximity Read

Mechanisms of superior respiratory IgA responses against SARS-CoV-2 after mucosal vaccinationSemantic proximity Read

Waning of Serum Antibodies, But Increase of Protective B-Cell Memory Nine Months After BNT162b2 VaccinationSemantic proximity Read

Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccinesSemantic proximity Read

Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated vaccineSemantic proximity Read

Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccinationSemantic proximity Read

Detection of anti–SARS-CoV-2 mucosal IgA in clinical saliva samples after a dose of Novavax COVID-19 vaccineSemantic proximity Read

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunizationSemantic proximity Read

SARS-CoV-2 oral tablet vaccination induces neutralizing mucosal IgA in a phase 1 open label trialSemantic proximity Read